Literature DB >> 21399660

Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis.

T Tomita1, Y Sakurai, S Ishibashi, Y Maru.   

Abstract

We have previously shown that tumor necrosis factor (TNF)α produced from primary tumor-induced expression of two endogenous Toll-like receptor 4 (TLR4) ligands, S100A8 and serum amyloid A3 (SAA3), in pre-metastatic lungs. However, mechanistic details of the signaling network and relevance to pulmonary physiology are poorly understood. Here, we identify Clara cells as a control tower of the network. Clara cell ablation by naphthalene suppressed pulmonary recruitment of CD11b+TLR4+ cells and spontaneous lung metastasis. Clara cells turned out to express TLR4 through which SAA3 was auto-amplified. Reciprocal bone marrow transplantation between wild-type and TLR4 knockout mice demonstrated that pulmonary TLR4+ Clara cells could be derived from bone marrow. SAA3-induced TNFα expression in both alveolar type II cells and macrophages. Primary co-cultures of alveolar type II cells and Clara cells revealed that the induction of TNFα in alveolar type II cells was dependent on the Clara cell-mediated amplification of SAA3. SAA3 induction by bacterial endotoxin also required both Clara cells and TLR4. Thus, pulmonary metastatic soil may feature deregulation of homeostatic inflammatory responses to constant assaults of microbes with endotoxin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21399660     DOI: 10.1038/onc.2011.53

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Authors:  A Deguchi; T Tomita; U Ohto; K Takemura; A Kitao; S Akashi-Takamura; K Miyake; Y Maru
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 2.  The lung metastatic niche.

Authors:  Yoshiro Maru
Journal:  J Mol Med (Berl)       Date:  2015-11       Impact factor: 4.599

Review 3.  Macrophage-epithelial interactions in pulmonary alveoli.

Authors:  Jahar Bhattacharya; Kristin Westphalen
Journal:  Semin Immunopathol       Date:  2016-05-12       Impact factor: 9.623

Review 4.  The emerging roles of macrophages in cancer metastasis and response to chemotherapy.

Authors:  Luis Rivera Sanchez; Lucia Borriello; David Entenberg; John S Condeelis; Maja H Oktay; George S Karagiannis
Journal:  J Leukoc Biol       Date:  2019-02-05       Impact factor: 4.962

5.  Tumor-polarized GPX3+ AT2 lung epithelial cells promote premetastatic niche formation.

Authors:  Zixin Wang; Jie Zhu; Yanfang Liu; Ziqiao Wang; Xuetao Cao; Yan Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

6.  Premetastatic soil and prevention of breast cancer brain metastasis.

Authors:  Yan Liu; Akemi Kosaka; Maki Ikeura; Gary Kohanbash; Wendy Fellows-Mayle; Linda A Snyder; Hideho Okada
Journal:  Neuro Oncol       Date:  2013-04-17       Impact factor: 12.300

7.  A protective Hsp70-TLR4 pathway in lethal oxidant lung injury.

Authors:  Yi Zhang; Xuchen Zhang; Peiying Shan; Clayton R Hunt; Tej K Pandita; Patty J Lee
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

Review 8.  The metastatic niche and stromal progression.

Authors:  Jonathan P Sleeman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 9.  Particle-induced pulmonary acute phase response may be the causal link between particle inhalation and cardiovascular disease.

Authors:  Anne T Saber; Nicklas R Jacobsen; Petra Jackson; Sarah Søs Poulsen; Zdenka O Kyjovska; Sabina Halappanavar; Carole L Yauk; Håkan Wallin; Ulla Vogel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-06-12

10.  ZFC3H1, a zinc finger protein, modulates IL-8 transcription by binding with celastramycin A, a potential immune suppressor.

Authors:  Takeshi Tomita; Katsuaki Ieguchi; Frédéric Coin; Fredric Coin; Yasuhiro Kato; Haruhisa Kikuchi; Yoshiteru Oshima; Shoichiro Kurata; Yoshiro Maru
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.